Lyra therapeutics announces publication of preclinical pharmacokinetics and drug release characterization for xtreo™ technology platform in the american journal of rhinology & allergy

Results demonstrate xtreo™ technology platform provides targeted and sustained dosing of anti-inflammatory medication

LYRA Ratings Summary

LYRA Quant Ranking